Dianthus Therapeutics (DNTH) Enterprise Value Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -47.03% |
| Sep 30, 2025 | -43.22% |
| Jun 30, 2025 | 29.00% |
| Mar 31, 2025 | 30.18% |
| Dec 31, 2024 | -57.95% |
| Sep 30, 2024 | -48.06% |
| Jun 30, 2024 | -552.98% |
| Mar 31, 2024 | -1,408.63% |
| Dec 31, 2023 | -130.12% |
| Sep 30, 2023 | -78.89% |
| Jun 30, 2023 | 60.38% |
| Mar 31, 2023 | 84.04% |
| Dec 31, 2022 | 57.33% |
| Sep 30, 2022 | 44.90% |
| Jun 30, 2022 | 32.91% |
| Mar 31, 2022 | -18.38% |
| Dec 31, 2021 | -18.87% |
| Sep 30, 2021 | -19.10% |
| Jun 30, 2021 | -17.74% |
| Mar 31, 2021 | -1.44% |
| Dec 31, 2020 | -2.13% |
| Sep 30, 2020 | -0.72% |
| Jun 30, 2020 | -2.45% |
| Mar 31, 2020 | -2.43% |
| Dec 31, 2019 | -2.22% |
| Sep 30, 2019 | -0.46% |
| Jun 30, 2019 | 0.76% |
| Dec 31, 2018 | -176.48% |
| Sep 30, 2018 | -166.62% |
| Jun 30, 2018 | -172.17% |